569 related articles for article (PubMed ID: 20305407)
1. Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.
Oki GC; Zantut-Wittmann DE; de Oliveira Santos A; Guariento MH; Tambascia MA; de Almeida EA; Amorim BJ; Lima MC; Etchebehere EC; Camargo EE; Ramos CD
Clin Nucl Med; 2010 Apr; 35(4):223-7. PubMed ID: 20305407
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 99mTc-methoxyisobutyl isonitrile and 201T1 scintigraphy in visualization of suppressed thyroid tissue.
Erdil TY; Onsel C; Kanmaz B; Caner B; Sönmezoğlu K; Ciftçi I; Turoğlu T; Kabasakal L; Sayman HB; Uslu I
J Nucl Med; 2000 Jul; 41(7):1163-7. PubMed ID: 10914905
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-sestamibi thyroid uptake in euthyroid individuals and in patients with autoimmune thyroid disease.
Santos AO; Zantut-Wittmann DE; Nogueira RO; Etchebehere EC; Lima MC; Tambascia MA; Camargo EE; Ramos CD
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):702-7. PubMed ID: 15703932
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Piga M; Cocco MC; Serra A; Boi F; Loy M; Mariotti S
Eur J Endocrinol; 2008 Oct; 159(4):423-9. PubMed ID: 18603573
[TBL] [Abstract][Full Text] [Related]
5. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.
Giordano A; Meduri G; Marozzi P; Rubini G; Burroni L; Cappagli M
Nucl Med Commun; 2003 Mar; 24(3):321-6. PubMed ID: 12612474
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hemiagenesis.
Sari O; Ciftçi I; Törü M; Erbaş B
Clin Nucl Med; 2000 Oct; 25(10):766-8. PubMed ID: 11043712
[TBL] [Abstract][Full Text] [Related]
7. 99Tc(m)-MIBI scanning of the thyroid gland in patients with markedly decreased pertechnetate uptake.
Alonso O; Mut F; Lago G; Aznarez A; Núñez M; Cánepa J; Touya E
Nucl Med Commun; 1998 Mar; 19(3):257-61. PubMed ID: 9625501
[TBL] [Abstract][Full Text] [Related]
8.
Zhao L; Zhang W; Xin Y; Wen Q; Bail L; Guan F; Bin J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):349-353. PubMed ID: 30413358
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the neoplastic potential of solitary solid thyroid lesions with Tc-99m-pertechnetate and Tc-99m-sestamibi scanning.
Wei JP; Burke GJ
Ann Surg Oncol; 1995 May; 2(3):233-7. PubMed ID: 7641020
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of
Wang J; Zhang R
Br J Radiol; 2017 Mar; 90(1071):20160836. PubMed ID: 28106465
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.
Klain M; Maurea S; Cuocolo A; Colao A; Marzano L; Lombardi G; Salvatore M
Eur J Nucl Med; 1996 Dec; 23(12):1568-74. PubMed ID: 8929309
[TBL] [Abstract][Full Text] [Related]
12. Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism.
Wiersinga WM; Touber JL; Trip MD; van Royen EA
J Clin Endocrinol Metab; 1986 Aug; 63(2):485-91. PubMed ID: 3013921
[TBL] [Abstract][Full Text] [Related]
13. Cutoff value of thyroid uptake of (99m)Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study.
Uchida T; Suzuki R; Kasai T; Onose H; Komiya K; Goto H; Takeno K; Ishii S; Sato J; Honda A; Kawano Y; Himuro M; Yamada E; Yamada T; Watada H
Endocr J; 2016; 63(2):143-9. PubMed ID: 26581846
[TBL] [Abstract][Full Text] [Related]
14. 201Tl scintigraphy does not allow visualization of the thyroid in euthyroid and hyperthyroid patients treated with amiodarone.
van de Wiele C; Osmanagaoglu K; Monsieurs M; van Laere K; Kaufman JM; Dierckx RA
Nucl Med Commun; 1997 Jun; 18(6):513-6. PubMed ID: 9259521
[TBL] [Abstract][Full Text] [Related]
15. Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a Saudi population.
Alshahrani A; Syed GM; Khan AH; Numani SP; Alnaim A; Alanazi F; Mahzari MM
Ann Saudi Med; 2021; 41(2):86-90. PubMed ID: 33818150
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.
Hou H; Hu S; Fan R; Sun W; Zhang X; Tian M
Biomed Res Int; 2015; 2015():974689. PubMed ID: 25879041
[TBL] [Abstract][Full Text] [Related]
17. Decreased thyroid uptake of Tc-99m pertechnetate in patients with advanced-stage Sjögren syndrome: evaluation using salivary gland scintigraphy.
Taura S; Murata Y; Aung W; Ishida R; Zhang L; Hossain M; Takahashi Y; Okada N; Shibuya H
Clin Nucl Med; 2002 Apr; 27(4):265-9. PubMed ID: 11914666
[TBL] [Abstract][Full Text] [Related]
18. Limited sensitivity of parathyroid imaging with (99m)Tc-sestamibi/(123)I subtraction in an endemic goiter area.
Rink T; Schroth HJ; Holle LH; Garth H
J Nucl Med; 2002 Sep; 43(9):1175-80. PubMed ID: 12215555
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99 m sestamibi imaging in patients with subacute thyroiditis.
Hiromatsu Y; Ishibashi M; Nishida H; Kawamura S; Kaku H; Baba K; Kaida H; Miyake I
Endocr J; 2003 Jun; 50(3):239-44. PubMed ID: 12940451
[TBL] [Abstract][Full Text] [Related]
20. Influence of (99m)Tc-pertechnetate thyroid imaging on radioactive iodine uptake.
Guo N; Yang K; Lin YS; Wang T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Jun; 36(3):267-70. PubMed ID: 24997818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
